# Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

> **NCT01494038** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 956 (actual)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Isoniazid (INH)
- **DRUG:** Placebo for isoniazid (INH)

## Key facts

- **NCT ID:** NCT01494038
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-19
- **Primary completion:** 2017-09-06
- **Final completion:** 2017-09-06
- **Target enrollment:** 956 (ACTUAL)
- **Last updated:** 2021-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494038, "Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01494038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*